Ultragenyx Pharmaceutical Inc. logo

Ultragenyx Pharmaceutical Inc. (0LIF)

Market Closed
23 Feb, 15:30
LSE LSE
$
22. 98
+0.52
+2.31%
$
- Market Cap
- P/E Ratio
760% Div Yield
609 Volume
-8.23 Eps
$ 22.46
Previous Close
Day Range
22.8 23.66
Year Range
18 42.86
Want to track 0LIF and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
0LIF earnings report is expected in 70 days (5 May 2026)
Name Time Cons. EPS Eps
Ultragenyx Pharmaceutical Inc. logo
RARE Ultragenyx Pharmaceutical Inc.
5 May 2026 (In 2 months)
-
-
Ultragenyx Pharmaceutical Inc. logo
RARE Ultragenyx Pharmaceutical Inc.
4 May 2026 (In 2 months)
-
-
Ultragenyx Pharmaceutical Inc. logo
RARE Ultragenyx Pharmaceutical Inc.
30 Apr 2026 (In 2 months)
-
-
Ultragenyx Pharmaceutical Inc. logo
RARE Ultragenyx Pharmaceutical Inc.
12 Feb 2026
-
-
Ultragenyx Pharmaceutical Inc. logo
RARE Ultragenyx Pharmaceutical Inc.
6 Nov 2025
-
-
Ultragenyx Pharmaceutical Inc. logo
RARE Ultragenyx Pharmaceutical Inc.
4 Nov 2025
-
-
Ultragenyx Pharmaceutical Inc. logo
RARE Ultragenyx Pharmaceutical Inc.
3 Nov 2025
-
-
Ultragenyx Pharmaceutical Inc. logo
RARE Ultragenyx Pharmaceutical Inc.
31 Jul 2025
-
-
Ultragenyx Pharmaceutical Inc. logo
RARE Ultragenyx Pharmaceutical Inc.
30 Apr 2025
-
-
Ultragenyx Pharmaceutical Inc. logo
RARE Ultragenyx Pharmaceutical Inc.
13 Feb 2025
-
-
Ultragenyx Pharmaceutical Inc. logo
RARE Ultragenyx Pharmaceutical Inc.
31 Oct 2024
-
-
Ultragenyx Pharmaceutical Inc. logo
RARE Ultragenyx Pharmaceutical Inc.
1 Aug 2024
-
-
Ultragenyx Pharmaceutical Inc. logo
RARE Ultragenyx Pharmaceutical Inc.
18 Jun 2024
-
-
Ultragenyx Pharmaceutical Inc. logo
RARE Ultragenyx Pharmaceutical Inc.
2 May 2024
-
-
Ultragenyx Pharmaceutical Inc. logo
RARE Ultragenyx Pharmaceutical Inc.
14 Feb 2024
-
-
Ultragenyx Pharmaceutical Inc. logo
RARE Ultragenyx Pharmaceutical Inc.
31 Oct 2023
-
-
Ultragenyx Pharmaceutical Inc. logo
RARE Ultragenyx Pharmaceutical Inc.
7 Nov 2016
-
-
Ultragenyx Pharmaceutical Inc. logo
RARE Ultragenyx Pharmaceutical Inc.
8 Aug 2016
-
-
Ultragenyx Pharmaceutical Inc. logo
RARE Ultragenyx Pharmaceutical Inc.
9 May 2016
-
-
Ultragenyx Pharmaceutical Inc. logo
RARE Ultragenyx Pharmaceutical Inc.
25 Feb 2016
-
-
Ultragenyx Pharmaceutical Inc. logo
RARE Ultragenyx Pharmaceutical Inc.
9 Nov 2015
-
-
Ultragenyx Pharmaceutical Inc. logo
RARE Ultragenyx Pharmaceutical Inc.
13 Aug 2015
-
-
Ultragenyx Pharmaceutical Inc. logo
RARE Ultragenyx Pharmaceutical Inc.
11 May 2015
-
-
Ultragenyx Pharmaceutical Inc. logo
RARE Ultragenyx Pharmaceutical Inc.
25 Mar 2015
-
-
Ultragenyx Pharmaceutical Inc. logo
RARE Ultragenyx Pharmaceutical Inc.
10 Nov 2014
-
-
Ultragenyx Pharmaceutical Inc. logo
RARE Ultragenyx Pharmaceutical Inc.
11 Aug 2014
-
-
Ultragenyx Pharmaceutical Inc. logo
RARE Ultragenyx Pharmaceutical Inc.
12 May 2014
-
-
Ultragenyx Pharmaceutical Inc. logo
RARE Ultragenyx Pharmaceutical Inc.
24 Mar 2014
-
-

0LIF Earnings Reports FAQ

What is the earnings per share (EPS) for 0LIF?

The current EPS is -8.23.

What is the company's earnings growth rate?

Ultragenyx Pharmaceutical Inc has not announced its next earnings release date. You can monitor upcoming announcements in Marketlog's earnings calendar or in the company profile.

When is the next earnings release date?

The next earnings release is expected to be on 2026-05-05, based on the 0LIF's typical earnings announcement schedule.

What were the most recent quarterly earnings?

The most recent quarterly earnings for Ultragenyx Pharmaceutical Inc are not available at this time.

What is the price-to-earnings (P/E) ratio?

There is no P/E ratio for 0LIF at this time, as Ultragenyx Pharmaceutical Inc has no recent EPS data to calculate it.